British Journal of Cancer - Table of Contents alert Volume 110 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 110, Issue 2 (269-547) Published online 21 January 2014 In this issue Editorial Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Corrigenda Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you read these most frequently accessed articles from British Journal of Cancer?  Cancer heterogeneity: implications for targeted therapeutics   A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions   Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer  Editorial Top Tumour-infiltrating lymphocytes in the risk stratification of squamous cell carcinoma of the head and neck T M Jones Br J Cancer 2014 110: 269-270; 10.1038/bjc.2013.746 Full Text Clinical Studies Top Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer K Shitara, S Yuki, D Tahahari, M Nakamura, C Kondo, T Tsuda, T Kii, Y Tsuji, S Utsunomiya, D Ichikawa, A Hosokawa, A Ishiguro, D Sakai, S Hironaka, I Oze, K Matsuo and K Muro Br J Cancer 2014 110: 271-277; advance online publication, November 26, 2013; 10.1038/bjc.2013.726 Abstract | Full Text Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study S Y Ryu, M H Kim, B H Nam, T S Lee, E S Song, C Y Park, J W Kim, Y B Kim, H S Ryu, S Y Park, K T Kim, C H Cho, C Lee, S M Kim, B G Kim, D S Bae, Y T Kim and J-H Nam Br J Cancer 2014 110: 278-285; advance online publication, December 19, 2013; 10.1038/bjc.2013.716 Abstract | Full Text Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry A Woehrer, M Hackl, T Waldhör, S Weis, J Pichler, A Olschowski, J Buchroithner, H Maier, G Stockhammer, C Thomé, J Haybaeck, F Payer, G von Campe, A Kiefer, F Würtz, G H Vince, R Sedivy, S Oberndorfer, F Marhold, K Bordihn, W Stiglbauer, U Gruber-Mösenbacher, R Bauer, J Feichtinger, A Reiner-Concin, W Grisold, C Marosi, M Preusser, K Dieckmann, I Slavc, B Gatterbauer, G Widhalm, C Haberler and J A Hainfellner on behalf of the Austrian Brain Tumour Registry Br J Cancer 2014 110: 286-296; advance online publication, November 19, 2013; 10.1038/bjc.2013.714 Abstract | Full Text Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy Y-M Tian, Y-H Tian, L Zeng, S Liu, Y Guan, T-X Lu and F Han Br J Cancer 2014 110: 297-303; advance online publication, December 12, 2013; 10.1038/bjc.2013.715 Abstract | Full Text SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours A Khatri, B W Williams, J Fisher, R C Brundage, V J Gurvich, L G Lis, K M Skubitz, A Z Dudek, E W Greeno, R A Kratzke, J K Lamba and M N Kirstein Br J Cancer 2014 110: 304-312; advance online publication, December 3, 2013; 10.1038/bjc.2013.738 Abstract | Full Text Adjuvant chemotherapy in elderly patients with pancreatic cancer A M Nagrial, D K Chang, N Q Nguyen, A L Johns, L A Chantrill, J L Humphris, V T Chin, J S Samra, A J Gill, M Pajic, Australian Pancreatic Cancer Genome Initiative, M Pinese, E K Colvin, C J Scarlett, A Chou, J G Kench, R L Sutherland, L G Horvath and A V Biankin Br J Cancer 2014 110: 313-319; advance online publication, November 21, 2013; 10.1038/bjc.2013.722 Abstract | Full Text Translational Therapeutics Top Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models H Zhang, B L Hylander, C LeVea, E A Repasky, R M Straubinger, A A Adjei and W W Ma Br J Cancer 2014 110: 320-329; advance online publication, December 10, 2013; 10.1038/bjc.2013.754 Abstract | Full Text Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer A Granata, R Nicoletti, V Tinaglia, L De Cecco, M E Pisanu, A Ricci, F Podo, S Canevari, E Iorio, M Bagnoli and D Mezzanzanica Br J Cancer 2014 110: 330-340; advance online publication, November 26, 2013; 10.1038/bjc.2013.729 Abstract | Full Text Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling L-H Wang, Y Li, S-N Yang, F-Y Wang, Y Hou, W Cui, K Chen, Q Cao, S Wang, T-Y Zhang, Z-Z Wang, W Xiao, J-Y Yang and C-F Wu Br J Cancer 2014 110: 341-352; advance online publication, December 3, 2013; 10.1038/bjc.2013.752 Abstract | Full Text PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer S Xiong, Y Zheng, P Jiang, R Liu, X Liu, J Qian, J Gu, L Chang, D Ge and Y Chu Br J Cancer 2014 110: 353-362; advance online publication, November 26, 2013; 10.1038/bjc.2013.728 Abstract | Full Text Molecular Diagnostics Top The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC A D Nygaard, P C Holdgaard, K-L G Spindler, N Pallisgaard and A Jakobsen Br J Cancer 2014 110: 363-368; advance online publication, November 14, 2013; 10.1038/bjc.2013.705 Abstract | Full Text The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma K Troppan, A Deutsch, A Gerger, T Stojakovic, C Beham-Schmid, K Wenzl, P Neumeister and M Pichler Br J Cancer 2014 110: 369-374; advance online publication, December 19, 2013; 10.1038/bjc.2013.763 Abstract | Full Text Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes D J E Peeters, P-J van Dam, G G M Van den Eynden, A Rutten, H Wuyts, L Pouillon, M Peeters, P Pauwels, S J Van Laere, P A van Dam, P B Vermeulen and L Y Dirix Br J Cancer 2014 110: 375-383; advance online publication, December 24, 2013; 10.1038/bjc.2013.743 Abstract | Full Text Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment Y H Park, H A Jung, M K Choi, W Chang, Y L Choi, I-g Do, J S Ahn and Y-H Im Br J Cancer 2014 110: 384-391; advance online publication, December 17, 2013; 10.1038/bjc.2013.757 Abstract | Full Text Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis J Lu, X Xu, X Liu, Y Peng, B Zhang, L Wang, H Luo, X Peng, G Li, W Tian, M He and X Li Br J Cancer 2014 110: 392-398; advance online publication, December 10, 2013; 10.1038/bjc.2013.751 Abstract | Full Text Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion S Khosravi, R P C Wong, G S Ardekani, G Zhang, M Martinka, C J Ong and G Li Br J Cancer 2014 110: 399-408; advance online publication, October 31, 2013; 10.1038/bjc.2013.688 Abstract | Full Text Pancreatic stellate cells promote hapto-migration of cancer cells through collagen I-mediated signalling pathway J Lu, S Zhou, M Siech, H Habisch, T Seufferlein and M G Bachem Br J Cancer 2014 110: 409-420; advance online publication, November 7, 2013; 10.1038/bjc.2013.706 Abstract | Full Text Death-associated protein-3, DAP-3, correlates with preoperative chemotherapy effectiveness and prognosis of gastric cancer patients following perioperative chemotherapy and radical gastrectomy Y Jia, L Ye, K Ji, L Zhang, R Hargest, J Ji and W G Jiang Br J Cancer 2014 110: 421-429; advance online publication, December 3, 2013; 10.1038/bjc.2013.712 Abstract | Full Text ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy Y Deng, J Zhou, L Fang, Y Cai, J Ke, X Xie, Y Huang, M Huang and J Wang Br J Cancer 2014 110: 430-434; advance online publication, December 10, 2013; 10.1038/bjc.2013.767 Abstract | Full Text The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer M Stotz, M Pichler, G Absenger, J Szkandera, F Arminger, R Schaberl-Moser, H Samonigg, T Stojakovic and A Gerger Br J Cancer 2014 110: 435-440; advance online publication, December 19, 2013; 10.1038/bjc.2013.785 Abstract | Full Text Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases C Kahlert, M Pecqueux, N Halama, H Dienemann, T Muley, J Pfannschmidt, F Lasitschka, F Klupp, T Schmidt, N Rahbari, C Reissfelder, C Kunz, A Benner, C Falk, J Weitz and M Koch Br J Cancer 2014 110: 441-449; advance online publication, November 28, 2013; 10.1038/bjc.2013.745 Abstract | Full Text MicroRNA-29a promotes colorectal cancer metastasis by regulating matrix metalloproteinase 2 and E-cadherin via KLF4 W Tang, Y Zhu, J Gao, J Fu, C Liu, Y Liu, C Song, S Zhu, Y Leng, G Wang, W Chen, P Du, S Huang, X Zhou, J Kang and L Cui Br J Cancer 2014 110: 450-458; advance online publication, November 26, 2013; 10.1038/bjc.2013.724 Abstract | Full Text Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients E C M Zeestraten, M S Reimers, S Saadatmand, J-W T Dekker, G J Liefers, P J van den Elsen, C J H van de Velde and P J K Kuppen Br J Cancer 2014 110: 459-468; advance online publication, November 5, 2013; 10.1038/bjc.2013.696 Abstract | Full Text Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction T Nagasaki, M Hara, H Nakanishi, H Takahashi, M Sato and H Takeyama Br J Cancer 2014 110: 469-478; advance online publication, December 17, 2013; 10.1038/bjc.2013.748 Abstract | Full Text Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance M M Gerlach, F Merz, G Wichmann, C Kubick, C Wittekind, F Lordick, A Dietz and I Bechmann Br J Cancer 2014 110: 479-488; advance online publication, November 21, 2013; 10.1038/bjc.2013.700 Abstract | Full Text Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer M J Ward, S M Thirdborough, T Mellows, C Riley, S Harris, K Suchak, A Webb, C Hampton, N N Patel, C J Randall, H J Cox, S Jogai, J Primrose, K Piper, C H Ottensmeier, E V King and G J Thomas Br J Cancer 2014 110: 489-500; advance online publication, October 29, 2013; 10.1038/bjc.2013.639 Abstract | Full Text Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer P Balermpas, Y Michel, J Wagenblast, O Seitz, C Weiss, F Rödel, C Rödel and E Fokas Br J Cancer 2014 110: 501-509; advance online publication, October 15, 2013; 10.1038/bjc.2013.640 Abstract | Full Text Genetics and Genomics Top An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma A Linton, Y Y Cheng, K Griggs, M B Kirschner, S Gattani, S Srikaran, S Chuan-Hao Kao, B C McCaughan, S Klebe, N van Zandwijk and G Reid Br J Cancer 2014 110: 510-519; advance online publication, December 10, 2013; 10.1038/bjc.2013.731 Abstract | Full Text Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling S R Lambert, N Mladkova, A Gulati, R Hamoudi, K Purdie, R Cerio, I Leigh, C Proby and C A Harwood Br J Cancer 2014 110: 520-529; advance online publication, December 12, 2013; 10.1038/bjc.2013.760 Abstract | Full Text Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study C M Phelan, J Iqbal, H T Lynch, J Lubinski, J Gronwald, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen, S L Neuhausen, L Senter, C F Singer, P Ainsworth, C Kim-Sing, N Tung, M Llacuachaqui, G Chornokur, S Ping, S A Narod and the Hereditary Breast Cancer Study Group Br J Cancer 2014 110: 530-534; advance online publication, November 28, 2013; 10.1038/bjc.2013.741 Abstract | Full Text BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface A J Lee, A P Cunningham, K B Kuchenbaecker, N Mavaddat, D F Easton and A C Antoniou The Consortium of Investigators of Modifiers of BRCA1/21 The Breast Cancer Association Consortium1 Br J Cancer 2014 110: 535-545; advance online publication, December 17, 2013; 10.1038/bjc.2013.730 Abstract | Full Text Corrigenda Top KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study N C T van Grieken, T Aoyama, P A Chambers, D Bottomley, L C Ward, I Inam, T E Buffart, K Das, T Lim, B Pang, S L Zhang, I B Tan, B Carvalho, D A M Heideman, Y Miyagi, Y Kameda, T Arai, G A Meijer, A Tsuburaya, P Tan, T Yoshikawa and H I Grabsch Br J Cancer 2014 110: 546; 10.1038/bjc.2013.824 Full Text Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer P Balermpas, Y Michel, J Wagenblast, O Seitz, C Weiss, F Rödel, C Rödel and E Fokas Br J Cancer 2014 110: 547; 10.1038/bjc.2013.825 Full Text Advertisement Have you read these top mini-reviews published in British Journal of Cancer?  Cancer heterogeneity: implications for targeted therapeutics Fisher, R et al.  Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Langley, RE et al.    Cancer chemoprevention: a rapidly evolving field Steward, WP et al.  Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.